Lanza Frank J 4
4 · Harpoon Therapeutics, Inc. · Filed Nov 29, 2022
Insider Transaction Report
Form 4
Lanza Frank J
Principal Fin. & Acctng Ofc.
Transactions
- Award
Employee Stock Option (right to buy)
2022-11-22+86,438→ 86,438 totalExercise: $0.70Exp: 2032-11-21→ Common Stock (86,438 underlying)
Footnotes (1)
- [F1]25% of the stock options vest every six months over two years measured from the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.